Breaking News Instant updates and real-time market news.

COTY

Coty

$7.06

-0.37 (-4.98%)

06:58
02/08/19
02/08
06:58
02/08/19
06:58

Coty up 19% to $8.40 after Q2 results beat estimates

  • 08

    Feb

  • 03

    Mar

COTY Coty
$7.06

-0.37 (-4.98%)

01/04/19
JPMS
01/04/19
UPGRADE
Target $7
JPMS
Neutral
Coty upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Andrea Teixeira upgraded Coty to Neutral with a $7 price target. The analyst's sum-of-the-parts analysis indicates Coty's valuation is "flushed out" at current levels. Teixeira, however, still sees potential downside to consensus estimates.
11/15/18
11/15/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Mylan (MYL) upgraded to Buy from Hold at Argus with analyst Jasper Hellweg saying the stock appears to be close to an inflection after several quarters of underperformance. 2. CopyTele (COPY) upgraded to Outperform from Market Perform at BMO Capital. 3. Voyager Therapeutics (VYGR) upgraded to Strong Buy from Outperform at Raymond James. 4. Athenex (ATNX) upgraded to Overweight from Neutral at JPMorgan with analyst Leon Chik saying more clinical data and progress in new drug trials should boost investor sentiment in 2019. 5. Coty (COTY) upgraded to Outperform from Market Perform at BMO Capital with analyst Shannon Coyne saying that her downgrade in August was driven by concerns around the company's supply chain issues, but believes that these factors have now been fully priced in after the management withdrew its guidance and consensus earnings have been pulled back by about 30%. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/15/18
BMOC
11/15/18
UPGRADE
Target $12
BMOC
Outperform
Coty upgraded to Outperform from Market Perform at BMO Capital
BMO Capital analyst Shannon Coyne upgraded Coty to Outperform from Market Perform and kept her price target at $12. The analyst says that her downgrade in August was driven by concerns around the company's supply chain issues, but believes that these factors have now been fully priced in after the management withdrew its guidance and consensus earnings have been pulled back by about 30%. With a 30% decline in the stock price over the past 10 weeks, Coyne states that the risk-reward on shares of Coty is now "compelling".
11/08/18
RBCM
11/08/18
NO CHANGE
Target $18
RBCM
Outperform
Coty price target lowered to $18 from $23 at RBC Capital
RBC Capital analyst Nik Modi lowered his price target on Coty to $18 after its lower than expected sales in Q1. The analyst notes that the market expectations for the company were already low after the management disclosed supply chain disruptions last weakness, adding that investors were further disappointed by "consumer beauty weakness and high leverage". Modi keeps his Outperform rating on Coty but believes that the stock is now more of a "2019 story", anticipating its top line to gradually improve and margins to expand on productivity efforts and synergies from the P&G acquisition.

TODAY'S FREE FLY STORIES

CDNS

Cadence Design

$72.68

-0.21 (-0.29%)

07:30
07/23/19
07/23
07:30
07/23/19
07:30
Recommendations
Cadence Design analyst commentary  »

Cadence Design price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMB

Kimberly-Clark

$134.40

-1.31 (-0.97%)

07:30
07/23/19
07/23
07:30
07/23/19
07:30
Earnings
Kimberly-Clark reports Q2 adjusted EPS $1.67, consensus $1.61 »

Reports Q2 revenue $4.6B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

T

AT&T

$32.14

-0.63 (-1.92%)

07:30
07/23/19
07/23
07:30
07/23/19
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 30

    Jul

  • 08

    Aug

WDDMF

WeedMD

$0.00

(0.00%)

07:30
07/23/19
07/23
07:30
07/23/19
07:30
Hot Stocks
WeedMD launches cannabis extraction affiliate CX Industries »

WeedMD announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKG

Asanko Gold

$0.83

0.0341 (4.29%)

, GFI

Gold Fields

$5.51

-0.16 (-2.82%)

07:28
07/23/19
07/23
07:28
07/23/19
07:28
Hot Stocks
Asanko Gold outlines 2H19 exploration program »

Asanko Gold (AKG)…

AKG

Asanko Gold

$0.83

0.0341 (4.29%)

GFI

Gold Fields

$5.51

-0.16 (-2.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADPT

Adaptive Biotechnologies

$39.16

0.61 (1.58%)

, MSFT

Microsoft

$138.41

1.79 (1.31%)

07:27
07/23/19
07/23
07:27
07/23/19
07:27
Initiation
Adaptive Biotechnologies, Microsoft, Roche initiated  »

Adaptive Biotechnologies…

ADPT

Adaptive Biotechnologies

$39.16

0.61 (1.58%)

MSFT

Microsoft

$138.41

1.79 (1.31%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 02

    Sep

  • 09

    Sep

  • 04

    Nov

NDAQ

Nasdaq

$101.77

0.05 (0.05%)

07:26
07/23/19
07/23
07:26
07/23/19
07:26
Hot Stocks
Nasdaq signs new agreement with Football Index »

Nasdaq announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

LII

Lennox

$264.15

-14.91 (-5.34%)

07:25
07/23/19
07/23
07:25
07/23/19
07:25
Recommendations
Lennox analyst commentary  »

Lennox price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

MRNS

Marinus Pharmaceuticals

$3.99

0.11 (2.84%)

07:25
07/23/19
07/23
07:25
07/23/19
07:25
Hot Stocks
Breaking Hot Stocks news story on Marinus Pharmaceuticals »

Marinus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRNE

Sorrento Therapeutics

$2.56

-0.04 (-1.54%)

07:23
07/23/19
07/23
07:23
07/23/19
07:23
Recommendations
Sorrento Therapeutics analyst commentary  »

Sorrento Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSY

Hershey

$147.16

1.98 (1.36%)

07:23
07/23/19
07/23
07:23
07/23/19
07:23
Recommendations
Hershey analyst commentary  »

Hershey price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

INAP

Internap

$2.76

-0.23 (-7.69%)

07:21
07/23/19
07/23
07:21
07/23/19
07:21
Hot Stocks
Internap launches Intelligent Monitoring managed cloud and monitoring service »

Internap Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLAB

Silicon Labs

$105.16

1.14 (1.10%)

07:21
07/23/19
07/23
07:21
07/23/19
07:21
Initiation
Silicon Labs initiated  »

Silicon Labs initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 13

    Sep

VIVE

Viveve

$0.41

-0.0155 (-3.68%)

07:21
07/23/19
07/23
07:21
07/23/19
07:21
Downgrade
Viveve rating change  »

Mizuho double downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDLZ

Mondelez

$54.64

-0.25 (-0.46%)

07:20
07/23/19
07/23
07:20
07/23/19
07:20
Recommendations
Mondelez analyst commentary  »

Mondelez price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

INTC

Intel

$51.36

1.1 (2.19%)

07:19
07/23/19
07/23
07:19
07/23/19
07:19
Initiation
Intel initiated  »

Intel initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 03

    Aug

TORC

ResTORbio

$11.18

1.15 (11.47%)

07:19
07/23/19
07/23
07:19
07/23/19
07:19
Hot Stocks
ResTORbio completes patient enrollment of Phase 3 PROTECTOR 1 trial »

resTORbio announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$264.15

-14.91 (-5.34%)

07:18
07/23/19
07/23
07:18
07/23/19
07:18
Recommendations
Lennox analyst commentary  »

Lennox price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

AGTC

Applied Genetic

$3.89

0.02 (0.52%)

07:18
07/23/19
07/23
07:18
07/23/19
07:18
Hot Stocks
Applied Genetic completes enrollment of third group in Phase 1/2 clinical study »

Applied Genetic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

PEBO

Peoples Bancorp

$31.80

0.08 (0.25%)

07:18
07/23/19
07/23
07:18
07/23/19
07:18
Earnings
Peoples Bancorp reports Q2 EPS 46c with items, consensus 68c »

Reports Q2 provision for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

VIVE

Viveve

$0.41

-0.0155 (-3.68%)

07:16
07/23/19
07/23
07:16
07/23/19
07:16
Downgrade
Viveve rating change  »

Viveve downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCI

Rogers Communications

$53.30

0.005 (0.01%)

07:16
07/23/19
07/23
07:16
07/23/19
07:16
Earnings
Rogers Communications reports Q2 adjusted EPS C$1.16 vs. C$1.07 last year »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

JBT

John Bean Technologies

$121.10

-0.995 (-0.81%)

07:16
07/23/19
07/23
07:16
07/23/19
07:16
Recommendations
John Bean Technologies analyst commentary  »

John Bean Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 19

    Sep

IEX

IDEX Corp.

$164.74

0.31 (0.19%)

07:15
07/23/19
07/23
07:15
07/23/19
07:15
Recommendations
IDEX Corp. analyst commentary  »

IDEX Corp. price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

ROP

Roper Technologies

07:14
07/23/19
07/23
07:14
07/23/19
07:14
Recommendations
Roper Technologies analyst commentary  »

Roper Technologies price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.